SEC Form 4 · accession 0001144204-15-055967
Akari Therapeutics Plc · AKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark S Cohen
Director
Period of report
Sep 18, 2015
Accepted (ET)
Sep 22, 2015 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001541157
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Sep 18, 2015 | P | 1,055,600 | $0.1895 | A | 1,055,600 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Ordinary SharesF2 | $0.3221 | Sep 21, 2015 | A | 85,000 | A | Sep 21, 2016 | Sep 21, 2025 | Ordinary Shares | 85,000 | 85,000 | D |
| Options to Purchase Ordinary SharesF2 | $0.3221 | Sep 21, 2015 | A | 186,278 | A | Sep 21, 2016 | Sep 21, 2025 | Ordinary Shares | 186,278 | 186,278 | D |
Explanation of responses
- F1The Company's American Depository Shares ("ADSs"), which began trading on The NASDAQ Capital Market under the symbol "AKTX" commencing on September 21, 2015, each represent 100 Ordinary Shares (giving effect to a previously announced ADS ratio change). The non-derivative and derivative equity securities described herein are listed in terms of Ordinary Shares rather than ADSs.
- F2All shares underlying the options will vest on September 21, 2016 and expire 10 years from issuance.